Metacrine, Inc.
DelistedCIK 1634379fmd_0RPV3WXW69V5M75ZMW1M52XZH9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2022, 13 periods
Latest annual · FY2021
Millions- Operating income
- (61)
- Net income
- (62)
- Free cash flow
- (47)
Latest quarter · Q3 FY2022
Millions- Operating income
- (5)
- Net income
- (6)
Metacrine, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$61.1 million | -$36.7 million | 10-K 2022-03-30 · proof | |
| Net income | -$62.2 million | -$37.3 million | 10-K 2022-03-30 · proof | |
| Cash from operating activities | -$47.2 million | -$36.2 million | 10-K 2022-03-30 · proof | |
| Free cash flow | -$47.2 million | -$36.4 million | 10-K 2022-03-30 · proof | |
| Total assets | $80 million | $104.2 million | -23.3% | 10-K 2022-03-30 · proof |
| Total liabilities | $22.6 million | $15 million | +51.3% | 10-K 2022-03-30 · proof |
| Cash and cash equivalents | $48.9 million | $24.4 million | +100.5% | 10-K 2022-03-30 · proof |
- What was Metacrine, Inc.'s operating income in fiscal 2021?
- Metacrine, Inc. reported operating income of -$61.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$36.7 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What was Metacrine, Inc.'s net income in fiscal 2021?
- Metacrine, Inc. reported net income of -$62.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$37.3 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What was Metacrine, Inc.'s cash from operating activities in fiscal 2021?
- Metacrine, Inc. reported cash from operating activities of -$47.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$36.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What was Metacrine, Inc.'s free cash flow in fiscal 2021?
- Metacrine, Inc. reported free cash flow of -$47.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$36.4 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What are Metacrine, Inc.'s total assets?
- As of Dec 31, 2021, Metacrine, Inc. reported total assets of $80 million, against $104.2 million a year earlier (-23.3%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What are Metacrine, Inc.'s total liabilities?
- As of Dec 31, 2021, Metacrine, Inc. reported total liabilities of $22.6 million, against $15 million a year earlier (+51.3%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
- What are Metacrine, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Metacrine, Inc. reported cash and cash equivalents of $48.9 million, against $24.4 million a year earlier (+100.5%). Source: the 10-K filed with the SEC on Mar 30, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1634379&period_type=annual&limit=5"Information only, not investment advice.